Lung endothelium, tau, and amyloids in health and disease

Physiol Rev. 2024 Apr 1;104(2):533-587. doi: 10.1152/physrev.00006.2023. Epub 2023 Aug 10.

Abstract

Lung endothelia in the arteries, capillaries, and veins are heterogeneous in structure and function. Lung capillaries in particular represent a unique vascular niche, with a thin yet highly restrictive alveolar-capillary barrier that optimizes gas exchange. Capillary endothelium surveys the blood while simultaneously interpreting cues initiated within the alveolus and communicated via immediately adjacent type I and type II epithelial cells, fibroblasts, and pericytes. This cell-cell communication is necessary to coordinate the immune response to lower respiratory tract infection. Recent discoveries identify an important role for the microtubule-associated protein tau that is expressed in lung capillary endothelia in the host-pathogen interaction. This endothelial tau stabilizes microtubules necessary for barrier integrity, yet infection drives production of cytotoxic tau variants that are released into the airways and circulation, where they contribute to end-organ dysfunction. Similarly, beta-amyloid is produced during infection. Beta-amyloid has antimicrobial activity, but during infection it can acquire cytotoxic activity that is deleterious to the host. The production and function of these cytotoxic tau and amyloid variants are the subject of this review. Lung-derived cytotoxic tau and amyloid variants are a recently discovered mechanism of end-organ dysfunction, including neurocognitive dysfunction, during and in the aftermath of infection.

Keywords: acute respiratory distress syndrome; beta-amyloid (Aβ); infection; pneumonia; tauopathy.

Publication types

  • Review

MeSH terms

  • Amyloid / chemistry
  • Amyloid / metabolism
  • Amyloid beta-Peptides / metabolism
  • Endothelium, Vascular / metabolism
  • Humans
  • Lung* / metabolism
  • Multiple Organ Failure* / metabolism

Substances

  • Amyloid
  • Amyloid beta-Peptides